I n the pharmaceutical industry, there is a clear need to improve human risk assessment by using early and more diverse toxicity assays. although the tendency still is to rely on whole animal experiments, mechanistic assays using in vitro approaches are increasingly being used early in the drug discovery phase. 1 in vitro investigations can be used to guide medicinal chemistry prior to the conduct of in vivo toxicology studies designed to support initial human trials. 1 indeed, in vitro profiling of compounds promises to provide information on molecular mechanisms of toxicity and may allow the creation of algorithms for predictive in vivo toxicology. 2 it has been estimated that up to 70% of assays developed for drug screening and discovery are cell-based assays. 3 this clearly stresses the need for well-developed and validated culture and treatment conditions for these cellular assays.
the advantages of label-free detection include a simple homogeneous assay format, noninvasive measurement, less interference with normal cell function, kinetic measurement, and reduced time for assay development. 8 real-time cell analyzer (rtca) methodology is one of these new label-free technologies and can be based on impedance measurement. rtca is used to gather information on different cellular processes, including cell proliferation, migration, cytotoxicity, and receptor-mediated signaling, as such processes are associated with very specific and well-defined changes in cell morphology and adhesion. 6 impedance is a measure of the total opposition to electric current flow in an alternating current circuit, made up of two components: ohmic resistance and reactance. the use of impedance as a cellular readout was described by Giaever and Keese in 1993. 9 in brief, impedance as generated on the xcelligence platform (roche diagnostics, Basel, switzerland) is measured on adherent cells attached to gold electrodes fixed at the bottom of wells (e.g., 96-well plate) by lithographic techniques. application of a small alternative current signal of 1 µa in the presence of media electrolytes leads to the generation of an electric field between the electrodes, which are impeded by the presence of cells. the factors affecting impedance (referred to as cell index) are the number of cells seeded in the wells, the way cells interact, the quality of interaction of the cells with the electrodes, and the overall morphology of the cells. 9 although carrying a lot of advantages, as with any technology, there are also some limitations associated with impedance-based label-free technology. For instance, nonadherent cells cannot be used as the cells need to attach to the gold electrodes to measure impedance. in addition, there may be some confounding factors that complicate the analysis of the rtca profiles. 6 please refer to the discussion section for more details. Finally, more data need to be generated with a large set of compounds to prove the good correlation between cellular impedance measurements and classical toxicity endpoints. recent applications of the xcelligence platform include, for instance, the long-term assessment of the immunotoxic effect of baboon sera on pig cells in the context of xenotransplantation, 10 the investigation of trophoblast function, 11 and the analysis of the cytotoxicity of dental composite components and okadaic acid on human gingival fibroblasts 12 and murine embryonic stem cells, 13 respectively. to our knowledge, there has been little publication dealing with the optimization of different cellular model culture conditions (e.g., cell density and coating) or reproducibility studies using impedance label-free technologies. in addition, the studies published did not perform such a systematic analysis using different adherent cell models compared with the present article. For instance, Kirstein et al. 3 explored the utility of the real-time cell electronic sensing system for monitoring the quality of live cells in cell-based assays as well as for assay development. the authors concluded that rtca provides high content and information-rich data that are beyond the scope of single-point assays. 3 more recently, huang et al. 14 investigated the effect of cell density on two lung epithelial cell lines (a549 and sK-mes-1) after 24 and 48 h. similarly, the effect of cell density on cell index was also reported using human gingival fibroblasts, 12 two types of trophoblast cells, 11 as well as keratinocytes and fibroblast cells. 15 nevertheless, none of the previously cited studies 11, 12, 14, 15 looked, for instance, at the effect of different coating conditions on cell index in combination with cell densities as well as reproducibility studies. clearly, the vast majority of the rtca publications based on impedance measurements focus on the effect of compounds on the profiles in pharmacology and/or toxicity applications. the objective of this study was to further assess the utility and reliability of impedance-based label-free technology in drug discovery and particularly in the field of in vitro and investigative toxicology. up to 4 cellular models, namely, hepG2, nd7/23, cardiomyocytes, and fibroblast cells, were used in the present study. the aims of this work were (1) to test different coating conditions and cell densities using impedance-based label-free technology to determine optimal culture conditions for each cellular model, (2) to check the reproducibility of the impedance assay in hepG2 cells exposed to 0.1% dmsO and 0.0025% triton X-100 in 31 independent experiments, (3) to evaluate the reproducibility of the cytotoxicity profiles obtained from cardiomyocytes and fibroblasts exposed to a set of 21 compounds in three independent experiments, and (4) to assess the meaning of impedance changes in nd7/23 cells exposed to cytochalasin B (a modulator of tubulin polymerization) by comparison with cellimaging readouts. 6 the xcelligence system (roche diagnostics, Vilvoorde, Belgium) measures real-time changes in electrical impedance across microelectrodes integrated into the bottom of a 96-well plate format (e-plates, roche diagnostics). to quantify cell status based on the measured cell-electrode impedance, a parameter termed cell index (ci) is derived, according to the following equation:
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Impedance, cell index measurements
where r b (f) and r cell (f) are the frequency-dependent electrode resistances (a component of impedance) without cells or with cells present, respectively, and n is the number of the frequency points at which the impedance is measured. thus, cell index is a quantitative measure of the overall status of the cells in an electrode-containing well. under the same physiological conditions, more cells attaching onto the electrodes lead to a larger r cell (f) value and then to a larger value for cell index. Furthermore, for the same number of cells present in the well, a change in the cell status such as morphology will lead to a change in the cell index. a normalized cell index at a given time point is calculated by dividing the cell index at the time point by the cell index at a reference time point. thus, the normalized cell index is 1 at the reference time point. the normalization is done using the last time point before compound addition. this allows comparing more precisely the effect of the different concentrations tested versus the control. the cell index values presented in this article were calculated from triplicate values (technical replicates) except when otherwise mentioned. data represent the average ± standard deviation. For more details concerning the rtca measurement principle, please refer to solly et al. 8
Cellular models used, cell culture, and manipulation of the cells
HepG2 cells. the human hepatocellular carcinoma cell line (hepG2) was purchased from the european collection of cell cultures (eccac; salisbury, uK). cells were maintained in dulbecco's modified eagle's medium supplemented with 10% fetal bovine serum, 50 u/ml penicillin, 50 g/ml streptomycin, 2 mmol/l l-glutamine, and 1X nonessential amino acid solution at 37 °c in a humidified 5% cO 2 /95% air atmosphere. medium was changed twice a week. cells were passaged as needed using 0.5% trypsin-edta. ND7/23 cells. the mouse neuroblastoma X rat neuron hybrid cell line was purchased from the eccac. cells were maintained in dulbecco's modified eagle's medium supplemented with 10% fetal bovine serum, 100 u/ml penicillin, 100 g/ml streptomycin, and 2 mmol/l l-glutamine at 37 °c in a humidified 5% cO 2 /95% air atmosphere. medium was changed twice a week. cells were passaged as needed using medium without trypsin-edta.
Mouse cardiomyocytes. the cells were purchased from axiogenesis (cologne, Germany). cells were unfrozen and directly seeded on e-plates in cor-at medium with 10 µg/ml puromycin (for 48 h). afterward, medium without puromycin was used, and cells were maintained in a humidified 5% cO 2 /95% air atmosphere.
Mouse fibroblasts. the cells were kindly provided by axiogenesis (cologne, Germany). cells have been unfrozen and seeded on e-plates (roche diagnostics) in cor-at medium without puromycin and maintained in a humidified 5% cO 2 /95% air atmosphere.
Quality control: test of different coating conditions and cell titration test. different conditions were tested to determine the optimal culture conditions for each cellular model. the following coating conditions were used: no coating, collagen (collagen r solution 0.2%; serva, heidelberg, Germany), fibronectin (sigma, st. louis, mO), and poly-d-lysine (sigma). e-plates were coated according to the manufacturer's recommendations. For each coating condition, different cell densities (0.625, 1.25, 2.5, 5, 10, 20, 40, and 80 × 10 3 cells per well) were tested in triplicate. the best combination (coating and cell density) was selected according to two important criteria. First, as recommended by the manufacturer (roche diagnostics), the cell index should be minimum 0.5 and ideally 1 (or above) before starting any experiment (i.e., before cells are exposed to compounds). second, the cell number selected should be in the cell index/cell number linear range. according to both criteria, the recommended (and used) conditions (cell density, coating) for the different cellular models are summarized below.
• hepG2 cells: 10 000 cells/well, collagen • nd7/23 cells: 10 000 cells/well, poly-d-lysine • mouse cardiomyocytes: 30 000 cells/well, fibronectin.
although it was our intention to use 30 000 cells/well, in practice 20 000 cells/well were used due to some technical limitations such as the number of cells in each vial and viability rate after thawing. • mouse fibroblasts: 2500 cells/well, fibronectin Assay Reproducibility Experiment 1. the 96-well e-plates were coated with collagen r according to the manufacturer recommendations. a total of 10 000 hepG2 cells per well were used. the background reading was performed in the presence of 100 µl of medium (and in absence of cells). then, the appropriate number of cells in 90 µl of culture medium was added to obtain the adequate cell density. the e-plates containing the cells were allowed to incubate at room temperature for 30 min in a laminar flow cabinet and placed on the plate reader in the incubator for continuous recording of impedance overnight. after 16 to 24 h (cell index = ±1), the cells were exposed to 0.1% dmsO (n = 6) and to 0.0025% triton X-100 (n = 2) for a minimum of 44 h. triton X-100 and dmsO stock solutions were freshly prepared before each experiment. the cells were monitored in real time, at 37 °c in a humidified 5% cO 2 /95% air atmosphere, using the multiplate (6 × 96-well plate format) xcelligence platform. intervals for data collection were every 10 min after compound addition for the first 2 h and every 30 min for minimum 44 h. the reproducibility of the impedance level of the hepG2 cells exposed to solvent and triton X-100 was evaluated using data from 31 experiments. For each graph, the mean impedance was calculated from t 0h (i.e., when compound is added) up to t 44h . the impedance value at each time point (from t 0h to t 44h ) was divided by the corresponding time point, and the average was calculated. the triton X-100 data are reported relative to the control impedance of the e-plate (set to 100%). to check for the variability, average, standard deviation, and coefficient of variation were calculated. Experiment 2. in the second experiment, a set of 21 compounds was tested. carboplatin, cyclophosphamide, docetaxel, etoposide, 5-fluorouracil, idarubicin, irinotecan, vinblastin, and vinorelbine were ordered from sigma-aldrich. dasatinib, daunorubicin, doxorubicin, epirubicin, imatinib, sorafenib, and sunitinib were purchased from sequoia research products (pangbourne, uK). Five proprietary compounds were also tested in experiment 2. the 96-well e-plates were coated with fibronectin (sigma) according to the manufacturer's recommendations for both mouse cardiomyocytes and fibroblasts. a total of 20 000 and 2500 cells per well were used for the cardiomyocytes and fibroblasts, respectively. the background reading was performed in the presence of 100 µl of medium (and in the absence of cells). then, the appropriate number of cells in 90 µl of culture medium was added to obtain the adequate cell density. the e-plates containing the cells were allowed to incubate at room temperature for 30 min and placed on the plate reader in the incubator for continuous recording of impedance overnight. after 16 to 24 h (cell index = approximately 1), the cells were exposed to the compounds for 48 to 72 h. Fresh concentrated stock solutions were prepared in dmsO immediately before use and then kept at -20 °c. cells were exposed to 0.1, 1, 10, and 100 µm for most of the compounds. depending on preliminary cytotoxicity data and possible solubility problems, other concentrations have also been tested (0.05, 0.5, 5, and 50 µm or 0.0125, 0.125, 1.25, and 12.5 µm). the cells were monitored in real time, at 37 °c in a humidified 5% cO 2 /95% air atmosphere, using the multiplate (6 × 96-well plate format) xcelligence platform. intervals for data collection after compound addition were every 10 min after compound addition for the first 2 h and every 30 min for 48 to 72 h. For each cell type, the experiments were performed three times (biological triplicates) and the assay reproducibility was statistically evaluated (correlation analysis). comparisons were performed at the 24-and 48-h time points. Because of the high number of tied results (e.g., lc 50 >100), the correlation has been assessed with the nonparametric Gamma statistics. 16 For each cellular model, a coefficient of correlation was also measured when an lc 50 was obtained at a given time point (4, 24 or, 48 h) in the three experiments (at least in one cellular model). three coefficients of correlation were calculated (experiments: 1 versus 2, 1 versus 3, and 2 versus 3), and the average ± standard deviation was reported.
Comparison between cell index (RTCA) and cell number, cell surface (cell imaging) in ND7/23 cells exposed to cytochalasin B (a modulator of tubulin polymerization)
nd7/23 cells were exposed to 1.1, 3.3, 10, and 30 µm of cytochalasin B. cell impedance was measured for 69 h. concerning cell imaging, 5000 nd7/23 cells per well were plated and allowed to adhere for 2 h. Various cell-imaging parameters (e.g., cell number, cell surface) were measured after 24, 48, and 69 h. cells were fixed and stained with the hcs cellmask Blue Whole cell stain (invitrogen, carlsbad, ca) following the recommendations of the manufacturer. the measurements were performed on the cellomics arrayscan V ti (thermo scientific, pittsburg, pa) using the morphology bio application (346/442 nm). parameters such as cell surface, cell perimeter, and total cell intensity were evaluated. to determine viability, all cells per well were counted (objective 5×-9 fields) with the target activation bio application (346/442 nm).
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Effect of different coating conditions
although 8 different cell densities were tested from 625 up to 80 000 cells/well in combination with 4 different coating conditions (namely, no coating, collagen r, fibronectin, and poly-d-lysine), our intention was certainly not to present all the data. the effect of the 4 coating conditions in combination with 2500, 10 000, and 40 000 cells/well using hepG2, nd7/23, cardiomyocytes, and fibroblast cells are presented in Figures 1,  2, 3 , and 4, respectively.
the highest cell index values were obtained when hepG2 cells were coated on poly-d-lysine and collagen r, independent of the cellular densities used ( Fig. 1) . nevertheless, cell index increased in a more linear way when collagen r was used particularly with a cell density of 40 000 cells/well ( Fig. 1c) . consequently, in subsequent experiments, hepG2 cells were coated with collagen r. the attachment of hepG2 cells on the plastic flask (no coating) or fibronectin led to much lower cell index values in comparison with the two other coatings ( Fig. 1) .
the best coating condition for nd7/23 cells was fibronectin when 2500, 10 000, and 40 000 cells/well were used, as presented in Figure 2 . nevertheless, when 2500 nd7/23 cells/well were used, similar results were obtained when cells were coated on the plastic flask (no coating) or poly-d-lysine or fibronectin ( Fig. 2A) . the least suitable coating condition for the nd7/23 cells was obtained with collagen r irrespective of the cellular densities used (Fig. 2) . Fibronectin was selected for subsequent experiments with nd7/23 cells.
When 2500 cardiomyocytes/well were used, none of the 4 coating conditions used gave satisfactory results (Fig. 3A) . nevertheless, at higher cell densities (i.e., 10 000 and 40 000 cells/well), fibronectin was the best coating condition. in other words, cell index increased over time in a linear manner when cardiomyocytes were coated on fibronectin ( Fig. 3b and 3c) . On the other hand, cell index values did not increase over time when 10 000 or 40 000 cardiomyocytes/well were seeded on the plastic flask (no coating) or collagen r or poly-d-lysine ( Fig. 3b and 3c ). Fibronectin was thus selected when cardiomyocytes were tested in the following experiments.
Finally, when 10 000 or 40 000 fibroblast cells were used per well, a lack of linearity for the cell index was clearly observed with the 4 different coating conditions tested ( Fig. 4b and 4c ). nevertheless, fibronectin was the best coating condition when a cell density of 2500 fibroblasts per well was used ( Fig. 4A) . collagen r was the second best condition followed by no coating and poly-d-lysine with a cell density of 2500 fibroblasts per well (Fig. 4A) .
Effect of different cell densities
Our objective was to select the optimal cell density condition for the following experiments according to two important criteria. First, as recommended by the manufacturer (roche the cell density data were generated with the best coating conditions as described in the previous section. to simplify the analysis of the data, cell index versus cell density was plotted after 12-and 48-h adherence (Fig. 6) . For all cellular models (except cardiomyocytes), high cell densities (e.g., 40 000 and 80 000 cells/well) led to a loss of proportionality, and this was particularly marked after 48 h of adherence ( Fig. 6e, 6F, and 6H) . similar curves were obtained with hepG2 ( Fig. 6A and 6e) and diagnostics), cell index should be minimum 0.5 and ideally 1 (or greater) before starting any experiment (e.g., before cells are exposed to compounds; rule 1). second, the cell number selected should be in the cell index/cell number linear range (rule 2). an overview of the effect of cell density on cell index is presented with hepG2 ( Fig. 5A) , nd7/23 (Fig. 5b) , cardiomyocytes (Fig. 5c) , and fibroblasts (Fig. 5d) cells. nd7/23 ( Fig. 6b and 6F) cells. For both cellular models, a cell density of 10 000 cells per well was selected in agreement with rules 1 and 2. On the other hand, a quasi linear response between cell index and cell number was observed with cardiomyocytes ( Fig. 6c and 6d) . nevertheless, the cell density of 30 000 cardiomyocytes per well was selected to satisfy rule 1 particularly after 12-h attachment. concerning the fibroblast data, even with relatively low amount of cells (e.g., 5000 cells/per well), relative high cell index values were obtained (cell index close to 5 after 12 or 48 h of adherence; Fig. 6d and 6H) . after 48-h adherence, cell densities in the range of 5000 to 80 000 fibroblasts per well provoked a loss of proportionality. the cell density selected for the fibroblasts was 2500 cells per well in agreement with rules 1 and 2.
Summary of the best cellular conditions for each cell model studied
a summary of the best cellular conditions for each cell model studied is presented in Supplemental table 1.
Assay reproducibility
Experiment 1. in a first experiment, hepG2 cells from different passages were exposed to 0.1% dmsO in 31 independent experiments. the data are presented in Supplemental Figure  1A . the average impedance value was 1.74 (mean impedance calculated from t 0h up to t 44h ), with a standard deviation of 0.19 and a coefficient of variation of 11%. the minimum and maximum mean impedance values were 1.54 and 2.19, respectively. hepG2 cells were also exposed to 0.0025% triton X-100 in the same 31 independent experiments (Supplemental Fig. 1b) . the mean triton X-100 impedance value was 54% of the control level, with a standard deviation of 5% and a coefficient of variation of 9%. the minimum and maximum mean impedance values were 46.8% and 64% of the control level, respectively. Experiment 2. in the second experiment, mouse cardiomyocytes and fibroblasts were exposed to 21 compounds, and the experiments were performed three times (biological replicates) to check for reproducibility. lc 50 data determined at 4, 24, and 48 h are presented in table 1. the analysis of the data from both cellular models at 24 and 48 h clearly indicates that the assay is reproducible. the coefficient gamma of correlation was 0.92 and 0.91 for cardiomyocytes and fibroblasts, respectively (p < 0.0001). When an lc 50 was obtained at a given time point in the three experiments (in at least one cellular model), a coefficient of correlation was calculated. the average coefficient of correlation was 95.82 ± 2.09% for the mouse cardiomyocytes and 95.93 ± 2.17% for the mouse fibroblasts. table 1 shows that similar lc 50 values were generally obtained when both cellular models are compared. Finally, Supplemental Figure 2 shows an example of data obtained with mouse cardiomyocytes and fibroblasts exposed to doxorubicin and daunorubicin, respectively. a visual and qualitative inspection of the graphs clearly confirms the high level of reproducibility of the data (Supplemental Figure 2) .
Comparison between cell index (RTCA) and cell number, cell surface (cell imaging) in ND7/23 cells exposed to cytochalasin B
the objective was to demonstrate that a decrease in cell index is not always associated with mortality and that the combination of rtca and cellular imaging allows better understanding of mechanisms of action. in this experiment, nd7/23 cells were exposed to cytochalasin B, and cell index was measured for 69 h. in parallel, cell-imaging analysis was performed after 24, 48, and 69 h. the corresponding rtca graphs are presented in Figure 7 , and a summary of both experiments is displayed in table 2. cytochalasin B induced a sudden decrease in cell index at all concentrations tested (1.1, 3.3, 10, and 30 µm; Fig. 7) . nevertheless, cell index stayed flat at least for the two highest concentrations even after 69 h. after 24-h exposure, cell index increased mainly for cells exposed to 1.1 µm cytochalasin B (Fig. 7) . cell-imaging data revealed that cell viability (according to cell number data) was not affected after 24-h exposure except for hepG2 cells exposed to 30 µm (table 2). thus, after 24-h exposure, there was not a good correlation between cell index and cell number, at least in cells exposed to 1.1, 3.3, and 10 µm of cytochalasin B. after 48-and 69-h exposure, cell viability (measured by cell imaging) was affected at all concentrations tested with a maximum of 31% in comparison to its control value set to 100% (taking into account both time points and all concentrations tested). the data also show that cell surface increased significantly in hepG2 cells exposed to 30 µm cytochalasin B after 24-h exposure but also in cells exposed to cytochalasin B at all concentrations after 48-and 69-h treatment (table 2). For instance, cell surface increased up to four to five times in cells exposed to 3.3, 10, and 30 µm of cytochalasin B after 69-h exposure in comparison with the control cells. dIScuSSIon the size and diversity of chemical libraries have significantly increased up to a maximum of a few millions of compounds. the challenge is certainly to triage among such compound diversity and identify lead compounds by means of high-throughput screening using relevant in vitro models. most cellular assays that rely on the detection of radio emission, absorbance, fluorescence, and luminescence usually require a labeled ligand, enzyme substrate, or tracer molecules. 8 these conventional label and reporter-based cell assays may be more prone to artifacts because of considerable manipulation of the cell either by the label or overexpression of targets or reporter proteins as well as the change of behavior of the tagged protein. 17 the drawback of the traditional approaches are the potential interference with physiological conditions, the complexity of the assays in case of cell wash, interference with the compound, and cost of labels. 8 cellbased, label-free technologies preclude the need for cellular labeling or overexpression of reporter proteins. indeed, such approaches use the inherent morphological and adhesive characteristics of the cell as a physiologically relevant and quantitative readout for various cellular assays. 17 Furthermore, these technologies use noninvasive measurements, allowing the performance of kinetic measurements. consequently, research is focusing more and more toward the development of label-free detection methodologies for cell-based assays. 18 among them, rtca measuring impedance has already shown great potential in many applications, such as investigations of cell adherence, cell spreading, cell shape change, cell migration, cell growth inhibition, and cytoprotection, and for safety and efficacy experiments. indeed, compounds with a similar mode of action produce similar rtca profiles, and consequently, impedance measurements may give information on potential off-target interactions. 6 For instance, specific profiles/signatures have been obtained with nuclear hormone modulators, antimitotics, dna damaging, and protein synthesis inhibitor compounds. 6 depending on the cellular models used (hepG2, heparG, and primary rat hepatocytes), some of the profiles were successfully reproduced in our laboratory, particularly with hepG2 cells (data not shown).
despite the growing interest and use of rtca in drug discovery, we thought that it was important to demonstrate that this technology is sufficiently reliable and robust to be potentially applied in medium-throughput screening. consequently, our objective was to show the utility of rtca to find rapidly optimal culture conditions with different cellular models including hepatocytes, cardiomyocytes, fibroblasts, and hybrid neuroblastoma/neuronal cells and to evaluate the reproducibility of the assay in different experiments. Because of the increased reliance on cells in drug discovery, cellular quality control and consistency are of great concern. 3,19 each cell's physiology is unique, complex, and subject to change in vitro depending, for example, on cell handling, growth, and nutrient conditions. this is clearly illustrated in the present article, as the four cellular models investigated behaved quite differently when different coating and cell densities were tested (Fig. 5) . Before testing any compounds on a given cell type, it is key to find the best condition for each cell type to ascertain consistency and reproducibility. nd7/23 cells were exposed for 69 h to 1.1, 3.3, 10, and 30 µm of cytochalasin B, as indicated in the table. pictures of the cells at 24, 48, and 69 h and at all concentrations tested are presented in the table. the same magnification was used to generate all the pictures. ci = cell index; cn = cell number; cs = cell surface. ci was determined according to the graphs presented in Figure 7 . cn (equivalent to the number of nuclei) and cs were determined by cell imaging. all data presented have been normalized. each data point was calculated from triplicate values. data represent the average ± standard deviation. For more details, please refer to the materials and methods section. unfortunately, traditional quality control methods, which rely on phenotypic visual inspection by microscopy and viability dye staining, are time-consuming and usually performed at a single time point. Kirstein and collaborators 3 have demonstrated that, based on the rtca technology, different cell types display unique growth kinetic profiles that provide a quantitative account of cell behavior and can be used as a diagnostic tool for cellular quality control. the present article clearly shows that different coating conditions have a great influence on cell adhesion and spreading depending on the cellular models used. For instance, mouse cardiomyocytes and fibroblasts grew well on fibronectin, whereas hepG2 and nd7/23 cells easily expanded on collagen r and poly-d-lysine, respectively. poly-d-lysine-mediated cell adhesion is allowed through charge-charge interaction with the plasma membrane glycoproteins, whereas fibronectin interacts with integrin receptors. Beside the coating conditions, cell density is also an essential parameter to optimize as cell density will greatly influence adhesion, spreading, lag phase, exponential growth phase, and confluence. Our data show that, generally, too many cells affect the proportionality between cell index and cell number, whereas a low number of cells leads to unworkable cell index values. the best densities varied from 2500 to 30 000 cells per well depending on the cellular models ( Supplemental table 1) .
Before using a technology for any application, it is also important to make sure that reproducibility among the same experiments is optimal. Based on 31 independent experiments, the present study reveals that the cell index kinetics generated in hepG2 were reproducible for negative (0.1% dmsO) and positive (0.0025% triton X-100) controls, with a coefficient of variation close to 10%. in a second investigation, mouse cardiomyocytes and fibroblasts were exposed to 21 compounds for 48 h, and the experiments were repeated three times (biological triplicates). the goal was to determine the reproducibility of the lc 50 values determined at 24 and 48 h. Our data show that the reproducibility was optimal, with a coefficient of correlation of minimum 0.91 (p < 0.0001) for both cellular models at two time points. Xing et al. 20 (2006) have also shown that the rtca assay provided good intralaboratory reproducibility according to variance analysis and with coefficient of variation (based on the 24-h ic 50 values for four chemicals, n = 6) ranging from 5.1 to 15.6 %.
in drug discovery, the main advantages of the rtca technology (e.g., xcelligence) can be summarized as follows: no cellular labeling or overexpression of reporter proteins, very low or no interaction with cell physiology, noninvasive measurements, kinetic evaluation in a real-time mode, easiness to set up recovery experiments, sensitive cell-monitoring platform, good quality control platform, some applications in toxicology 10, 12, 13, [20] [21] [22] and pharmacology, 6, 23 and reasonable throughput. compared with traditional assays, the throughput with the xcelligence platform (6 × 96-well plate) is generally significantly improved. For instance, some traditional cytotoxicity screen 24 (multiplexing approach) allow for the screen of 28 compounds per week, whereas 82 compounds can be screened per week in 3-day cytotoxicity experiments. different studies (but limited in numbers) have also revealed a high correlation between impedance-based determination of viable adherent cells and mtt evaluation in different cell types. 21, 25, 26 more recently, Vistejnova et al. 15 compared the xcelligence platform with commonly used metabolic-based techniques in 4 different cell types. impedance correlated well with mtt and adenosine triphosphate (atp) evaluation for keratinocytes (hacat) and fibroblasts (nhdF, 3t3) but not for human keratinocytes (nheK). the lack of correlation could be due to specific morphological features of the nheK cells. 15 such data clearly emphasize the need to perform quality control experiments before launching any further investigations with different cell types.
to better understand the signature obtained in neuroblastoma (nd7/23) cells with cytochalasin B (a modulator of tubulin polymerization), cell-imaging data at 24, 48, and 69 h were compared with rtca profiles. cytochalasin B induced a brutal decline in cell index within a few hours for all concentrations tested (1.1-30 µm) with a flat signal for 10 and 30 µm up to 69 h, which was not linked to a decrease in cell viability according to cell-imaging data ( Fig. 7; table 2) . thus, the initial decline in cell index is likely to be due to morphological changes as cytochalasin B induces, in vitro, a rapid disorganization of normal microfilament bundles. 27 using the same magnification, the cell-imaging data also revealed that the cells were much bigger than control cells after 24 to 69 h of exposure, which correlates with an increase in cell index at 1.1 and 3.3 µm. Overall, a decline in cell index should not be always considered as a decrease in cell viability; neither should an increase in cell index always be considered as cell proliferation. indeed, cell index values depend on the number of cells seeded in the wells, the way cells interact, the quality of interaction of the cells with the electrodes, and the overall morphology of the cells. 9 consequently, the interpretation of the cell index data is not necessarily always easy, and the combination of rtca and cell imaging may be a powerful tool to better understand mechanisms of action. nevertheless, pharmacological effects (target effect) occur generally rapidly after compound addition, whereas cytotoxicity will appear after a longer period. in other words, experienced rtca users should be able to distinguish both effects, but ambiguity is still possible.
there are also some drawbacks associated with the rtca methodology. the classification and interpretation of profiles depend on the end-user experience and thus are subjected to human approximation. the development of a reliable analysis tool (e.g., an interpretation/classification algorithm) is needed to standardize the interpretation of rtca patterns. Furthermore, a cell index decrease is not always associated with cytotoxicity effects, and there may be some confounding factors that affect the analysis, particularly in the case of cytotoxicity investigations. For instance, compounds affecting the cytoskeleton such as cytocholasin B (present study) or modulators of calcium 6 (e.g., triflupromazine, imipramine) induce a brutal decrease in cell index that is associated with changes in cell morphology and attachment at concentrations that are not cytotoxic. the confounding factors may be explained by the fact that cell index is influenced by changes in multiple cell status such as cell morphology, cell size, cell number, and adherence. in addition, the platform is more costly compared with traditional equipment and can be used only with adherent cells. Finally, to convince more researchers to use rtca in early toxicity screening, it will be necessary to show that there is a good correlation between cellular impedance measurements and classical toxicity endpoints (e.g., cell number, atp) with a large number of compounds (e.g., a few hundred). indeed, until now, there has been limited data available showing such correlation.
in conclusion, despite some limitations, the rtca technology appears to be a powerful and reliable tool in drug discovery because of the reasonable throughput, the facility to perform technical optimization and quality control, and the possibility of monitoring in real time cell responses to compounds at an early stage of drug development. the assay was reproducible with the xcelligence platform (6 × 96-well plate) in a set of experiments. For high-throughput screening applications requiring a higher throughput (e.g., 384), researchers are encouraged to run similar experiments to define optimal cellular conditions and to check for assay reproducibility before intensive use of the technology.
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